Education
About Us
Working with TipRanks
Follow Us
Eckert & Ziegler Strahlen und Medizintechnik (DE:EUZ)
:EUZ
RESEARCH TOOLSreports
Total Valuation
Eckert & Ziegler Strahlen und Medizintechnik has a market cap or net worth of €1.38B. The enterprise value is €919.31M.
Market Cap€1.38B
Enterprise Value€919.31M
Share Statistics
Eckert & Ziegler Strahlen und Medizintechnik has 21,171,932 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,171,932
Owned by Insiders31.13%
Owned by Institutions―
Financial Efficiency
Eckert & Ziegler Strahlen und Medizintechnik’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 11.27%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)11.27%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee272.67K
Profits Per Employee37.67K
Employee Count1,085
Asset Turnover0.67
Inventory Turnover3.48
Valuation Ratios
The current PE Ratio of Eckert & Ziegler Strahlen und Medizintechnik is 27.88. Eckert & Ziegler Strahlen und Medizintechnik’s PEG ratio is 1.20.
PE Ratio27.88
PS Ratio0.00
PB Ratio7.08
Price to Fair Value4.15
Price to FCF29.49
Price to Operating Cash Flow24.20
PEG Ratio1.20
Income Statement
In the last 12 months, Eckert & Ziegler Strahlen und Medizintechnik had revenue of 295.85M and earned 33.28M in profits. Earnings per share was 1.60.
Revenue295.85M
Gross Profit143.16M
Operating Income61.07M
Pretax Income58.36M
Net Income33.28M
EBITDA80.96M
Earnings Per Share (EPS)1.60
Cash Flow
In the last 12 months, operating cash flow was 66.81M and capital expenditures -17.19M, giving a free cash flow of 49.62M billion.
Operating Cash Flow66.81M
Free Cash Flow49.62M
Free Cash Flow per Share2.34
Dividends & Yields
Eckert & Ziegler Strahlen und Medizintechnik pays an annual dividend of €5.599, resulting in a dividend yield of 0.65%
Dividend Per Share€5.599
Dividend Yield0.65%
Payout Ratio87.08%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.24
52-Week Price Change60.82%
50-Day Moving Average63.40
200-Day Moving Average52.07
Relative Strength Index (RSI)48.18
Average Volume (3m)23.02K
Important Dates
Eckert & Ziegler Strahlen und Medizintechnik upcoming earnings date is Aug 8, 2025, TBA (Confirmed).
Last Earnings DateMay 13, 2025
Next Earnings DateAug 8, 2025
Ex-Dividend DateJun 19, 2025
Financial Position
Eckert & Ziegler Strahlen und Medizintechnik as a current ratio of 3.12, with Debt / Equity ratio of 14.39%
Current Ratio3.12
Quick Ratio2.51
Debt to Market Cap0.02
Net Debt to EBITDA-0.78
Interest Coverage Ratio16.30
Taxes
In the past 12 months, Eckert & Ziegler Strahlen und Medizintechnik has paid 17.49M in taxes.
Income Tax17.49M
Effective Tax Rate0.30
Enterprise Valuation
Eckert & Ziegler Strahlen und Medizintechnik EV to EBITDA ratio is 10.68, with an EV/FCF ratio of 17.51.
EV to Sales2.92
EV to EBITDA10.68
EV to Free Cash Flow17.51
EV to Operating Cash Flow12.99
Balance Sheet
Eckert & Ziegler Strahlen und Medizintechnik has €118.36M in cash and marketable securities with €55.34M in debt, giving a net cash position of -€63.03M billion.
Cash & Marketable Securities€118.36M
Total Debt€55.34M
Net Cash-€63.03M
Net Cash Per Share-€2.98
Tangible Book Value Per Share€8.42
Margins
Gross margin is 48.75%, with operating margin of 20.64%, and net profit margin of 11.25%.
Gross Margin48.75%
Operating Margin20.64%
Pretax Margin19.73%
Net Profit Margin11.25%
EBITDA Margin27.37%
EBIT Margin20.99%
Analyst Forecast
The average price target for Eckert & Ziegler Strahlen und Medizintechnik is €67.55, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€67.55
Price Target Upside4.49% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast15.89%
EPS Growth Forecast14.62%